Morgan Stanley’s Longevity Health Holdings XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-467
Closed -$1.75K – 8333
2025
Q1
$1.75K Hold
467
– – ﹤0.01% 7199
2024
Q4
$3.91K Buy
467
+398
+577% +$3.78K ﹤0.01% 7071
2024
Q3
$836 Hold
69
– – ﹤0.01% 7251
2024
Q2
$2.77K Hold
69
– – ﹤0.01% 7000
2024
Q1
$5.33K Hold
69
– – ﹤0.01% 6878
2023
Q4
$7.93K Hold
69
– – ﹤0.01% 6728
2023
Q3
$7.5K Buy
+69
New +$10.4K ﹤0.01% 6814

Other funds holding XAGE

Morgan Stanley's XAGE Position: Q2 2025 in Review

Morgan Stanley sold out of Longevity Health Holdings (XAGE) in Q2 2025, closing a stake of 467 shares — an estimated $1.75K sold.

Morgan Stanley first reported a position in XAGE in Q3 2023 and held it in 7 quarters. The position peaked at $7.93K in Q4 2023. 11 funds tracked by Wall St. Rank hold XAGE as of Q2 2025.

  • Morgan Stanley reported no remaining Longevity Health Holdings position as of Q2 2025 after selling out during the quarter.
  • Morgan Stanley sold 467 Longevity Health Holdings shares in Q2 2025, an estimated $1.75K.
  • Morgan Stanley first reported a position in Longevity Health Holdings in Q3 2023 and held it in 7 quarters.
  • Morgan Stanley's Longevity Health Holdings position peaked at $7.93K in Q4 2023.
  • 11 funds tracked by Wall St. Rank held Longevity Health Holdings as of Q2 2025.

Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.